First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience
Ingrid Holst Olsen, Seppo W Langer, Ida Jepsen, Maria Assens, Birgitte Federspiel, Jane Preuss Hasselby, Carsten Palnaes Hansen, Andreas Kjaer, Ulrich Knigge
13Citations
(Scopus)
Fingerprint
Dive into the research topics of 'First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience'. Together they form a unique fingerprint.